Viewing nowCombinationLacor Tablet 120/12.5 mg
Fimasartan Potassium Trihydrate 132.02mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dongwha Pharmaceutical Co., Ltd.

MFDS item code 201309443 · Approved 2013.09.27 · Insurance code 642706220
Improvement in blood pressure control for essential hypertension
This medication is used for essential hypertension that is not adequately controlled by monotherapy with pimasartan.
The recommended dosage of this medication is one tablet once a day, taken with water regardless of meals. It is advisable to take it at the same time daily (e.g., morning). If blood pressure is not adequately controlled with 60 mg of pimasartan, it is recommended to gradually switch to this medication at doses of 60/12.5 mg or 120/12.5 mg.
The safety and efficacy of this medication have not been established for pediatric and adolescent patients under the age of 18.
This medication can cause serious harm to the fetus if taken during pregnancy, especially during the second and third trimesters. Therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to any of the components contained in this medication or those with certain kidney and liver diseases or electrolyte imbalances should not take this medication. Patients with reduced blood volume or salt, impaired kidney function, or heart valve diseases should use this medication cautiously and monitor their status closely while taking it. This medication has blood pressure-lowering effects, thus there is a need for vigilance as symptoms of hypotension may occur upon initial use or dosage increase. Dizziness or drowsiness may occur, so caution should be exercised when driving or operating hazardous machinery. There may be an increased risk of skin cancer; therefore, care should be taken to avoid excessive sun exposure, and any unusual skin changes should be reported to a physician immediately. This medication can affect potassium levels, so it is important to regularly check potassium concentrations via blood tests. It can interact with other antihypertensives, diuretics, and some analgesics, so patients should inform their doctor about any other medications they are taking. Women who are breastfeeding are advised to avoid taking this medication, or if necessary, to discontinue breastfeeding or consult their doctor. Overdose may lead to hypotension, electrolyte imbalances, and dehydration symptoms, requiring immediate medical attention. The safety and efficacy of this medication have not been established for children and adolescents under 18 years of age, necessitating caution in its use. Elderly patients may have reduced kidney and liver function, so it is advisable to start at a lower dosage and monitor their condition closely.
Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, mucous membrane pain in the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headaches, lightning-like headaches, seizures, confusion of consciousness, visual disturbances, paralysis,
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that is light-proof. Additionally, it should be kept at a temperature between 1 and 30 degrees Celsius at room temperature. This will help maintain the effectiveness and safety of the medication.
Orange oval film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate 132.02mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dongwha Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 132.02mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dongwha Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.